Clinical trials in metastatic hormone-refractory prostate cancer: improving docetaxel therapy by targeting bone-related growth factors.
Petrylak
Daniel P
DP
Department of Medicine, Division of Medical Oncology, Columbia-Presybeterian Medical Center, New York, NY 10032, USA. dpp5@columbia.edu